SCHEMBL21661808

SCHEMBL21661808

COc1cc2c(cc1C)C(O)N(C)C2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 4/20 0.39
MAOB P27338 2/20 0.37
SLC6A4 P31645 1/20 0.37
KCNN2 Q9H2S1 4/20 0.36
KCNN3 Q9UGI6 4/20 0.36
KCNN1 Q92952 2/20 0.36
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 2/20 0.35
GLA P06280 2/20 0.35
HPGD P15428 2/20 0.35
CASP1 P29466 2/20 0.35
CASP7 P55210 2/20 0.35
HSD17B10 Q99714 2/20 0.35
BRD4 O60885 1/20 0.35
CYP2D6 P10635 1/20 0.35
ACHE P22303 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
RAD52 P43351 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18415360 0.83 ACHE (0.39) MAOAMAOBSLC6A4KCNN2KCNN3
SCHEMBL18256786 0.78 MAOA (0.54) MAOAKCNN2KCNN3KCNN1KDM4E
SCHEMBL27283990 0.73 KDM4E (0.36) SLC6A4KDM4EALDH1A1GLAHPGD
SCHEMBL18256785 0.73 SLC6A4 (0.40) MAOAMAOBSLC6A4CYP2D6CYP3A4
SCHEMBL22297377 0.72 SLC6A2 (0.50) SLC6A4
SCHEMBL18256759 0.70 MAOA (0.77) MAOAKCNN2KCNN3KCNN1KDM4E
SCHEMBL20073096 0.69 SLC6A2 (0.49) SLC6A4KDM4EALDH1A1GLAHPGD
SCHEMBL12192725 0.68 MAOA (0.49) MAOAKCNN2KCNN3KCNN1KDM4E
SCHEMBL30666505 0.68 ACHE (0.36) ACHECYP3A4MAPT
SCHEMBL11466963 0.68 UGT2B17 (0.46) MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3604304-A1 PYRROLO-PYRIDINE DERIVATIVE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF PROTEIN KINASE-RELATED DISEASES Daegu-Gyeongbuk Medical Innovation Foundation (KR) 2020-02-05 EP disclosed